diabetes

Roche Diagnostics cutting 100 jobs in diabetes restructuring
Tue, 10/23/12 - 11:04 pm
Roche
diabetes
job cuts
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Merck
Sanofi
Eli Lilly
diabetes
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Amylin
Roche continues to restructure diabetes unit
Indianapolis Business Journal, IN
Tue, 10/23/12 - 09:17 am
Roche
restructuring
diabetes
layoffs
Novo Nordisk: Encouraging Pipeline News
Seeking Alpha
Tue, 10/23/12 - 09:13 am
Novo Nordisk
Tresiba
Ryzodeg
diabetes
Lilly Diabetes Medicine Meets Goal in Three Studies
Bloomberg
Mon, 10/22/12 - 11:23 am
diabetes
Eli Lilly
dulaglutide
Novo's long-acting insulin degludec takes big step to megamarket status
Fierce Biotech
Fri, 10/19/12 - 12:20 pm
degludec
Novo Nordisk
diabetes
insulin
Europe
Tresiba
Lexicon Pharma: Blockbuster Potential From A Diabetes Drug
TheStreet.com
Tue, 10/16/12 - 10:40 am
diabetes
Lexicon Pharmaceuticals
LX4211
sodium-dependent glucose transporter
Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline
Yahoo/Reuters
Fri, 10/12/12 - 12:11 pm
diabetes
Lexicon Pharmaceuticals
carcinoid syndrome
LX1032
LX4211
Diabetes: Dexcom sinks on FDA approval for continuous glucose monitor
Tue, 10/9/12 - 11:16 pm
diabetes
DexCom
FDA
glucose
Diabetes: Medtronic sues Insulet over OmniPod device
Tue, 10/9/12 - 11:15 pm
diabetes
Medtronic
Insulet
Omnipod
lawsuit
legal
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tue, 10/9/12 - 09:55 am
obesity
Novo Nordisk
Merck
Bristol-Myers Squibb
diabetes
Sanofi
Lilly Backs Broad Diabetes Range to Challenge Rivals
Bloomberg
Mon, 10/8/12 - 12:53 pm
Eli Lilly
diabetes
Boehringer Ingelheim
Amylin
LY2605541
GLP-1 agonist
SGLT2 inhibitor
Much-hyped renal denervation devices could help diabetics, too
Sat, 10/6/12 - 10:40 pm
diabetes
renal denervation
New Diabetes Drug Can Bolster J&J’s $74 Value
Trefis
Sat, 10/6/12 - 12:05 pm
JNJ
diabetes
canagliflozin
type 2 diabetes
Pharma’s Diabetes War Escalates
Motley Fool
Sat, 10/6/12 - 11:54 am
diabetes
Merck
Amalin
Extending the Diabetes Dominance
Motley Fool
Sat, 10/6/12 - 11:49 am
Merck
MK-3102
Januvia
diabetes
type 2 diabetes
Novo to Hire 1,000 People in 2 Years in Emerging Markets
Bloomberg Businessweek
Fri, 10/5/12 - 12:23 pm
emerging markets
diabetes
Novo Nordisk
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Fri, 10/5/12 - 11:25 am
Bristol-Myers Squibb
Novo Nordisk
Amylin
diabetes
Big Pharma to benefit from growth in diabetes: S&P
Marketwatch
Fri, 10/5/12 - 11:18 am
diabetes
Big Pharma
Eli Lilly
Merck
Bristol-Myers Squibb
Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Bloomberg
Thu, 10/4/12 - 10:50 am
Sanofi
Lyxumia
diabetes
Bristol-Myers Squibb

Pages